Although an increased IENFD is commonly observed in acute or subacute lesions of AD, this phenomenon is thought to be closely associated with elevated levels of NGF and reduced expression of the axon-repelling molecule Semaphorin 3A (Sema3A) (80, 81). The gene discussed is NGF; the disease is Alzheimer disease.